| Literature DB >> 35202241 |
Jessica Phillips1,2, Alex S Haimbaugh1,2, Camille Akemann1,2, Jeremiah N Shields1, Chia-Chen Wu1,3, Danielle N Meyer1,2,3, Bridget B Baker1,4, Zoha Siddiqua5, David K Pitts5, Tracie R Baker1,2,3.
Abstract
Triclosan, triclocarban and 4-nonylphenol are all chemicals of emerging concern found in a wide variety of consumer products that have exhibited a wide range of endocrine-disrupting effects and are present in increasing amounts in groundwater worldwide. Results of the present study indicate that exposure to these chemicals at critical developmental periods, whether long-term or short-term in duration, leads to significant mortality, morphologic, behavioral and transcriptomic effects in zebrafish (Danio rerio). These effects range from total mortality with either long- or short-term exposure at 100 and 1000 nM of triclosan, to abnormalities in uninflated swim bladder seen with long-term exposure to triclocarban and short-term exposure to 4-nonylphenol, and cardiac edema seen with short-term 4-nonylphenol exposure. Additionally, a significant number of genes involved in neurological and cardiovascular development were differentially expressed after the exposures, as well as lipid metabolism genes and metabolic pathways after exposure to each chemical. Such changes in behavior, gene expression, and pathway abnormalities caused by these three known endocrine disruptors have the potential to impact not only the local ecosystem, but human health as well.Entities:
Keywords: 4-nonylphenol; Danio rerio; aquatic environment; detergents; development; environmental toxicity; ground water chemicals; triclocarbon; triclosan; zebrafish
Year: 2022 PMID: 35202241 PMCID: PMC8877790 DOI: 10.3390/toxics10020053
Source DB: PubMed Journal: Toxics ISSN: 2305-6304
Figure 1Heat map showing abnormality rate of zebrafish exposed to triclosan (A), triclocarban (B), or 4-nonylphenol (C) starting from 4 h post-fertilization to 5 days post-fertilization (0–5 dpf) or 4–5 dpf. ** indicates significant difference from control (p < 0.10), *** (p < 0.001).
Figure 2Average distance moved (cm) by larval zebrafish during light and dark cycles following (A) triclosan (TCS), (B) triclocarbon (TCC), or (C) 4-nonylphenol (4NP) exposure starting from 4 h post-fertilization to 5 days post-fertilization (dpf; 120 h exposure) or 4–5 dpf (24 h exposure): * indicates significant difference from control (p < 0.05), ** (p < 0.10), *** (p < 0.001); bars represent standard deviation.
Number of significantly dysregulated genes (significance defined as absolute log2-fold changes ≥ 0.75 and adjusted p-value < 0.1) in zebrafish following extended duration 4NP, TCC or TCS exposure starting at 4 h post-fertilization through 5 days post-fertilization, short term duration starting at 4 dpf through 5 dpf, and total genes dysregulated across all concentrations for extended duration and short term duration. ↓ indicates gene downregulation; ↑ indicates gene upregulation.
| Triclosan | ||||
|---|---|---|---|---|
| 0.1 nM | 1 nM | 10 nM | Total genes | |
| 24 h | 7 ↓, 15 ↑ | 2 ↓, 17 ↑ | 1 ↓, 3 ↑ | 10↓ 35↑ |
| 120 h | 11 ↓, 8 ↑ | 0 ↓, 1 ↑ | 3 ↓, 8 ↑ | 14 ↓ 17↑ |
|
| ||||
| 0.01 nM | 1 nM | 100 nM | Total genes | |
| 24 h | 115 ↓, 54 ↑ | 26 ↓,37 ↑ | 8 ↓, 9 ↑ | 149↓ 100↑ |
| 120 h | 0 ↓, 1 ↑ | 578 ↓, 258 ↑ | 478 ↓, 465 ↑ | 1056↓ 724↑ |
|
| ||||
| 0.01 nM | 10 nM | 1000 nM | Total genes | |
| 24 h | 0 ↓, 0 ↑ | 4 ↓, 34 ↑ | 8↓, 6 ↑ | 12 ↓ 40↑ |
| 120 h | 32 ↓, 7 ↑ | 1↓, 0 ↑ | 1 ↓, 0 ↑ | 33 ↓ 7↑ |
Figure 3Venn diagram of differentially expressed genes after exposure to triclosan (TCS), triclocarban (TCC) or 4-nonylphenol (4NP) with all exposure concentrations and durations combined. The genes included in this diagram have an adjusted p-value < 0.1 and absolute log2-fold changes >0.75.
Differential expression for all genes altered in zebrafish following extended duration 4NP, TCC or TCS exposure starting at 4 h post-fertilization through 5 days post-fertilization and short-term duration starting at 4 dpf through 5 dpf. Significant absolute log2-fold changes (value ≥ 0.75 and adjusted p-value < 0.1) in bold. (ND = no difference in expression). Purple background indicates significant differential expression across all 3 chemicals, yellow across 4NP and TCS, green across 4NP and TCC, and blue across TCC and TCS.
| Exposure Concentrations (nM) 0–5 Days | Exposure Concentrations (nM) 4–5 Days | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gene Name | 4-nonylphenol | Triclosan | Triclocarban | 4-nonylphenol | Triclosan | Triclocarban | |||||||||||||
| 0.1 | 10 | 1000 | 0.1 | 1 | 10 | 0.01 | 1 | 100 | 0.1 | 10 | 1000 | 0.1 | 1 | 10 | 0.01 | 1 | 100 | ||
| Cardiovascular | |||||||||||||||||||
|
| F-box protein 32 |
| −0.8 | −0.2 | 0.4 | 0.2 | 1 | −0.01 | 0.5 |
| 0.6 | 0.2 | −0.5 |
| 0.3 | 0.1 |
| −1.1 | −0.2 |
|
| transferrin receptor 1b | 0.4 | 0.2 | 0.3 | 0.1 | −0.1 | 0.2 | −0.03 | −0.1 |
| 0.6 |
| −0.2 | 0.2 | 0.1 | −0.4 | −0.9 | ||
|
| myosin, light chain 10, regulatory | −0.1 | 0.04 | −0.3 | −0 | 0.1 | −0 | −0.2 | 0.2 | −0.1 | 0.3 | 0.4 |
| 0.2 | 0.2 | −0.1 |
| −0.7 | 0.1 |
|
| methionine adenosyltransferase II, alpha a | −0.1 | 0.1 | 0.02 | −0 | −0 | 0.4 | −0.01 | −0.5 |
| −0.1 | 0.2 |
| −0.1 | 0.2 | 0.3 | −0.1 | 0.2 | 0.05 |
| hbae1.1 | hemoglobin, alpha embryonic 1.1 | −0.1 | 0.01 | −0.3 | −0.8 | −0.3 | −0.3 | 0.1 | −0.6 | −0.4 | −0.4 | −0.2 |
| −0.6 |
|
|
| −1.6 | −0.2 |
|
| t-complex 1 | 0.3 | −0.2 | −0.1 |
| −0.6 | −0.2 | 0.2 |
| −0.2 | −0.1 | −0.3 | 0.2 |
| 0.3 | 0.3 | −0.3 | −0.1 | −0.2 |
|
| hemoglobin beta embryonic- 1.2 | 0.2 | 0.3 | 0.04 | ND | −0.3 | −0.4 | 0.04 | −0.1 | −0.3 | −0 | −0.2 | 0.03 | −0.1 |
| 0.4 | −0.3 | −0.8 |
|
| Neurological | |||||||||||||||||||
|
| receptor accessory protein 3b | 0.5 | 0.7 | 0.2 | 0.6 | 0.03 | 0.2 | −0.4 | 0.2 | −0.2 | 0.5 |
| 0.2 |
| 0.1 | 0.01 | −0.3 | −1.4 | 0.1 |
|
| synaptogyrin 3b | −0.03 | 0.7 | 0.3 |
| 0.1 | 0.2 | −0.1 | 0.3 | −0.3 | 0.5 |
| 0.1 |
| 0.1 | −0.1 | 0.3 | −0.2 | −0.04 |
|
| anterior gradient 2 |
| 0.4 | −0.2 | −0.5 | −0.4 | −0.3 | 0.2 | −0.7 |
| −0.1 | −0.05 | 0.4 | −0.3 | 0.4 | 0.05 | −0.7 | −2.5 | −0.1 |
|
| crystallin, gamma M2d18 | −0.2 |
| −0.1 | 0.2 | 0.1 | −0.8 | 0.03 | 0.04 | −0.1 | −0.3 | 0.3 | −0.1 | −0.6 | 0.6 | 0.1 | −0.2 | −1 |
|
|
| engulfment and cell motility 2 | −0.2 | 0.4 | −0.1 | 0.2 | −0 | 0 | −0.3 | −0 | −0.2 | 0.4 |
| −0.04 | 0.4 | 0.5 | −0.1 | 0.5 | 1.4 | 0.02 |
|
| arrestin 3b, retinal (X- arrestin) | 0.1 | 0.4 | −0.02 | −0.1 | 0.2 | 0.1 | −0.3 | −0 |
| 0.2 |
| −0.2 | 0.1 | −0.1 | −0.2 | 0.04 | −0.4 | 0.2 |
|
| opsin 1 (cone pigments), short-wave-sensitive 2 | −0.1 | −0.01 | 0.2 | −0.2 | −0.3 |
| −0.1 | −0.1 | −0.3 | −0.3 | −0.4 | 0.2 | −0.4 | −0.4 | −0.3 |
|
| −0.1 |
|
| si:ch211-153b23.5 | 0.9 | 0.3 | −0.2 |
| −0.9 | −0.6 | 0.1 |
| 0.6 | 0.7 | 0.5 | 1 | −0.8 | 0.8 | 0.1 | −0.4 | 0.4 | 0.7 |
|
| microsomal glutathione S- transferase 3a | 0.3 | −0.1 | 0.1 |
| −0.9 | −0.3 | 0.2 |
| −0.5 | −0.5 | −0.5 | −0.1 |
| 0.4 | 0.3 | 0.02 | −0.5 | −0.4 |
|
| retinaldehyde binding protein 1b | 0.1 | 0.1 | 0.4 | −0 | −0 | 0.2 | 0.2 | 0.1 |
| 0.2 | −0.1 | 0.1 | 0.4 |
| 0.5 |
| −0.5 | 0.04 |
| Metabolic Processes | |||||||||||||||||||
|
| carboxyl ester lipase, tandem duplicate 1 |
| −0.7 | −0.3 | 0.6 | 0.4 | 0.2 | −0.3 | 0.5 | 0.4 | 0.1 | −0.3 | −0.5 |
| 0.2 | −0.3 | 0.05 | −0.6 | −0.5 |
|
| amylase alpha 2A |
| −0.7 | −0.1 |
| 0.4 | 0.2 | −0.1 | −0.2 | 0.5 | 0.1 | −0.2 |
| 0.8 | 0.4 | −0.2 | 0.4 | 0.4 | −0.6 |
|
| serine protease 59, tandem duplicate 2 |
| −0.4 | 0.04 | 0.3 | −0.1 | 0.2 | −0.1 |
| 0.1 | −0 | −0.2 | −0.4 | 0.4 |
| 0.2 | 0.1 | −0.3 | −0.4 |
|
| elastase 2 like | −0.7 | −0.3 | 0.06 | 0.3 | −0.5 | −0.6 | 0.2 | −0.2 | −0.1 | −0.5 |
| −0.4 | 0.5 | 0.4 |
| 0.1 | −0.8 | −0.3 |
|
| phosphatidylinositol-4- phosphate 5-kinase, type I, gamma b | 0.4 | 0.7 | 0.4 | 0.6 | 0.3 | 0 | −0.4 | 0 | −0.2 | 0.5 |
| 0.1 |
| −0.2 | −0.3 | 0.7 | −0.3 | 0.4 |
|
| fatty acid binding protein 10a, liver basic |
| −0.1 | −0.1 | 0.2 | 0.01 | 0.3 | −0.1 | 0.04 | −0.1 | −0.1 | −0.02 | −0.7 | 0.4 | 0.6 | 0.2 | 0.4 | −0.9 | −0.2 |
|
|
|
| −0.3 |
| −0 | −0 | 0 | −0.1 | −0.3 |
| −0.1 | 0.2 | −0.2 | 0.1 | 0.8 | 0.1 | −0.03 | −1.1 |
|
|
| si:ch211-234p6.10 |
| −0.03 | 0.4 | 0 | −0.2 | 0.2 | −0.04 | 0.1 | −0.3 | 0.4 | 0.1 |
| 0.3 | 0.6 | 0.2 |
| 0.3 | −0.4 |
|
| lipin 1 |
| −0.4 | −0.4 | 0.1 | −0 | 0.2 | −0.2 | 0.2 |
| 0.2 | −0 | −0.3 | 0.4 | 0.02 | −0.1 | 0.6 | 0.2 | −0.03 |
|
| FKBP prolyl isomerase 9 | 0.8 | 0.6 | −0.02 | −0.1 | −0.3 | 0 | −0.4 |
|
| −0 |
| 0.8 | −0.2 | −0.2 | 0.04 | −0.1 | −0.6 | −0.1 |
|
| ATP-binding cassette, sub- family C (CFTR/MRP), member 2 | −0.4 | 0.1 | −0.1 | 0.4 | 1 |
| −0.1 | 0.4 |
| 0.3 | 0.2 | 0.2 | 0.7 | −0.2 | 0.6 | −0.1 | 0.2 | −0.1 |
|
| perilipin 2 | 0.06 | −0.2 | 0.6 | −0 | 0.1 |
| −0.2 | −0.3 |
| 0.8 | 0.4 | 0.4 | 0.3 | 1 |
| 0.4 | −0.6 | −0.1 |
|
| farnesyl diphosphate synthase (farnesyl pyrophosphate synthetase, dimethylallyltranstransferas e, geranyltranstransferase) | 0.1 | 0.4 | 0.1 | −0.1 | −0.4 | 0.4 | 0.02 | −0.1 |
| 0.03 | 0.4 | 0.3 | 0.5 |
| 0.6 | 0.04 | 0.3 | 0.1 |
| Immune System | |||||||||||||||||||
|
| immunoresponsive gene 1, like |
| 0.2 | 0.04 | −0.5 | −0.2 | −0.2 | 0.2 |
|
| 0.8 | 0.4 | 0.6 | −0.3 | 0.8 | 0.2 | −0.3 | 0.6 | 1.1 |
|
| heat shock protein 90, beta (grp94), member 1 |
| 0.2 | 0.3 | −0.3 | −0.1 | −0.2 | 0.4 |
| 0.2 | 0.1 | −0.1 | 0.4 | −0.4 | −0.4 | 0.2 | −0.3 | −0.9 | −0.1 |
|
| cathepsin L.1 | −0.4 | 0.2 | −0.4 | 0.7 | 0.3 | −0.1 | −0.1 | −0.2 | 0.7 | 0.6 | 0.5 |
| 0.8 | 0.5 | −0.5 |
| −0.1 | −0.4 |
| Extracellular Processes | |||||||||||||||||||
|
| si:dkey-14d8.6 |
| −0.4 | 0.01 |
| 0.4 | 0 | −0.2 | −0.2 | 0.5 | 0.2 | −0.2 | −0.3 | 0.9 | 0.4 | −0.5 | 0.5 | −0.2 | −0.4 |
|
| pyruvate dehydrogenase kinase 2b |
| −0.5 | 0.004 | −0 | 0.2 |
| −0.1 | 0.3 |
| 0.5 | −0.2 | −0.5 | 0.3 | 0.4 | 0.3 |
| 0.5 | −0.6 |
|
| carboxypeptidase A1 (pancreatic) |
| −0.9 | −0.5 | 0.1 | 0.02 | 0.3 | −0.1 | −0.6 | −0.2 | −0.1 | −0.3 | −0.6 | 0.3 | 0.4 | 0.3 |
| −0.8 | −0.4 |
| Intracellular Processes | |||||||||||||||||||
|
| si:ch211-153b23.4 |
| −0.2 | −0.3 | −0.9 | −0.5 | −0.5 | 0.2 | −0.4 |
| 0.8 | 0.1 | 0.8 | −0.5 |
| 0.5 | −0.3 | 0.05 | 0.5 |
|
| tRNA on mitochondrial genome | −0.002 | −0.04 | −0.05 |
| −0.4 | −0.6 | 0.1 | 0.4 | 0.5 | −0.3 |
| −0.4 | −0.4 | 0.2 | 0.1 |
| −1.9 | −0.4 |
|
| PRELI domain containing 3 | 0.1 | 0.4 | 0.3 |
| 0.4 | 0.5 | −0.4 | 0.1 | −0.5 | 0.4 | 0.8 | 0.1 |
| 0.3 | −0.1 | 0.2 | −0.6 | 0.2 |
|
| heterogeneous nuclear ribonucleoprotein A0, like | 0.4 | 0.2 | −0.03 |
| −0.5 | −0.3 | 0.001 |
|
| 0.2 | 0.5 |
|
| 0.5 | 0.1 | −0.1 | 0.1 | −0.02 |
|
| calcium binding and coiled- coil domain 1b |
| −0.7 | −0.3 | 0.1 | 0.1 | 0.4 | 0.1 | 0.7 |
| 0.4 | −0.2 | −1.3 | 0.7 | 0.7 | 0.2 |
| 1.1 | −0.1 |
|
| MAPK interacting serine/threonine kinase 2b |
| −0.5 | −0.2 | 0 | 0.1 | 0.2 | 0.03 | −0.1 |
| −0 | −0.2 | −0.4 | 0.3 | 0.1 | −0 | 0.6 | −0.1 | 0.1 |
|
| tripartite motif containing 63a |
| −0.6 | −0.2 | −0.3 | −0.1 | 0.1 | 0.2 | 0.3 |
| 0.04 | −0.3 | −0.6 | 0.1 | 0.2 | −0.2 | 0.5 | −1.6 | −0.2 |
|
| si:ch211-207n23.2 |
| 0.3 | 0.03 | −0.5 | −0.4 | −0.5 | 0.3 | −0.3 |
| 0.8 | 0.5 | 0.2 | −0.3 | 0.5 | 0.1 | 0.2 | 0.3 | 0.4 |
|
| si:ch211-153b23.3 |
| −0.02 | −0.1 | −0.1 | −0 | −0 | 0.2 | 0.3 |
| 0.3 | 0.3 | 0.5 | −0 | 0.7 | 0.3 | −0.2 | 0.8 |
|
|
| sulfotransferase family 5A, member 1 |
| 0.7 | 0.1 | −0.1 | −0 | −0.1 | 0.1 | −0.2 |
| 0.4 | 0.3 | 0.2 | −0.1 | 1 | 0.1 | −0.3 | 0.9 | 0.7 |
|
| ATP synthase 8, mitochondrial | −0.5 | −0.4 | −0.7 | −0.4 | 0.2 | 0 | −0.2 |
| 0.1 | −0.7 |
| 0.2 | −0.3 | −0.4 | 0 | −0.5 | 0.2 | −0.1 |
|
| DGCR8 microprocessor complex subunit | 0.1 | 0.4 | 0.02 | 0.2 | 0.2 | 0.3 | −0.2 | 0.3 |
| 0.3 |
| 0.1 | 0.1 | −0.02 | 0.1 | 0.1 | 0.6 | 0.1 |
|
| BUB3 mitotic checkpoint protein | 0.2 | 0.3 | −0.04 | −0.2 | −0.1 | −0.1 | −0.1 |
|
| 0.3 |
| 0.7 | −0.1 | −0.1 | −0.1 | −0.3 | −1 | 0.5 |
|
| exportin, tRNA (nuclear export receptor for tRNAs) | −0.3 | 0.2 | −0.3 | 0.1 | −0 | −0.1 | −0.4 |
|
| 0.3 |
| 0.4 | −0 | −0.1 | −0.2 | 0 | 0.4 |
|
|
| si:ch211-250g4.3 | 0.1 | 0.3 | 0.3 | 0.7 | 0.4 | 0.7 | 0.1 |
|
| 0.3 |
| −0.05 | 0.8 | 0.5 | 0.3 |
| −0.2 | −0.02 |
|
| CCAAT enhancer binding protein delta | −0.1 | 0.03 | 0.04 | −0.4 | 0.1 | 0.6 | 0.2 | −0.2 |
| 0.1 | −0.5 |
| 0 | 0.4 | 0.4 |
| 0.01 | −0.2 |
|
| heterogeneous nuclear ribonucleoprotein A0a | 0.5 | 0.2 | −0.1 | −0.5 | −0.4 | −0.4 | −0.1 | −0.5 |
| 0.2 | 0.4 |
| −0.8 | 0 | 0.02 | −0.02 | −0.4 | −0.3 |
|
| FKBP prolyl isomerase 5 | −0.4 | 0.1 | 0.1 | 0.4 | 0.7 |
| 0.2 | −0.1 | 0.2 | 0.01 | −0.5 | 0.5 | 0.5 | −0.4 | ND |
| −0.02 | −0.03 |
|
| DEAD (Asp-Glu-Ala-Asp) box polypeptide 39Ab | 0.3 | −0.1 | −0.1 |
| −0.6 | −0.4 | 0.1 | −0.6 |
| −0.1 | −0.2 | 0.3 |
| 0.3 | 0.3 | −0.6 | −0.9 | −0.2 |
|
| tyrosinase-related protein 1b | 0.4 | −0.02 | 0.02 |
| −0.8 | −0.4 | 0.2 | −0.2 |
| −0.3 | −0.4 | −0.1 | −0.7 | 0.4 | 0.2 |
| −0.4 | −0.2 |
|
| heterogeneous nuclear ribonucleoprotein A0b | 0.5 | 0.2 | 0.3 |
| −0.5 | 0.2 | 0.2 |
|
| −0.2 | −0.01 | 0.2 | −0.6 | 0.3 | 0.4 | 0.1 | 0.6 | −0.1 |
|
| putative homeodomain transcription factor 2 | −0.4 | 0.2 | 0.2 | 0.5 | 0.2 | 0.2 | −0.2 | 0.3 | −0 | 0.3 | 0.3 | −0.1 |
| 0.2 | 0 | −0.2 | −2.4 | 0.2 |
|
| zmp:0000001081 | 0.2 | 0.1 | 0.3 | 0.7 | 0.3 | 0.6 | 0.2 | 0.2 |
| 0.2 | 0.7 | −0.3 |
| 0.5 | 0.2 |
| 0.2 | 0.2 |
|
| si:ch211-113a14.18 | −0.003 | −0.1 | 0.02 | 0.1 | 0.3 | 0.1 | 0.1 | 0.7 | 0.1 | −0.1 | −0.2 | −0.3 | −0.1 |
| −0.5 | 0.2 |
| −0.1 |
|
| zgc:113263 | −0.1 | −0.2 | 0.1 | 0.2 | 0.01 | 0 | −0.1 | 0.2 | 0.4 | 0.3 | 0.2 | 0.2 | 0.01 |
| −0.2 | 0.2 | 1.4 | 0.1 |
|
| si:ch211-132b12.7 | 0.1 | 0.4 | −0.1 | 0.2 | 0 | 0.7 | −0.3 | −0.2 |
| −0.2 | 0.5 | −0.1 | 0.9 |
| 0.5 | 0.1 | −0.03 | −0.1 |
|
| transmembrane 4 L six family member 21b | −0.02 | −0.4 | −0.2 | −0.1 | −0 | 0.2 | 0.3 |
| −0.4 | −0.5 | −0.5 | 0.1 | 0.1 |
| 0.6 | −0.3 | 0.2 | −0.6 |
| Xenobiotic Signaling | |||||||||||||||||||
|
| cytochrome P450, family 3,subfamily A, polypeptide 65 |
| −0.6 | −0.1 | 0.5 |
| 0.7 | 0.1 | 0.6 |
| 0 | −0.5 |
| 0.5 | 0.1 | 0.1 | −0.1 | −0.6 | −0.4 |
|
| uncoupling protein 1 |
| −0.4 | 0.1 | 0.5 | 0.1 | 0.4 | −0.1 | 0.3 |
| 0.1 | −0.2 | −0.5 | 0.7 | 0.9 | 0.1 | 0.7 | −0.1 | −0.5 |
|
| cytochrome P450, family 2, subfamily K, polypeptide18 | 0.3 | −0.03 | 0.2 | 0.2 |
|
| −0.1 | −0.1 |
| 0.2 | −0.2 | 0.6 | 0.1 | −0.2 | 0.3 | −0.2 | 2.4 | −0.5 |